Gara Jalqabaatti › Alopecia Areata
Qorannoo klinikaalii Alopecia Areata Ameerikaa Keessatti hirmaatuu
Qorannoo 17 Alopecia Areata f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Indianapolis, INQorannoo 7
- Miami, FLQorannoo 6
- San Antonio, TXQorannoo 6
- Omaha, NEQorannoo 5
- New York City, NYQorannoo 4
- Spokane, WAQorannoo 3
- Columbus, OHQorannoo 3
- Irvine, CAQorannoo 3
- Houston, TXQorannoo 3
- Troy, MIQorannoo 3
- Los Angeles, CAQorannoo 3
- Portland, ORQorannoo 3
Naannoon
- CaliforniaQorannoo 10
- FloridaQorannoo 8
- IllinoisQorannoo 3
- IndianaQorannoo 8
- MarylandQorannoo 5
- MassachusettsQorannoo 4
- MichiganQorannoo 5
- NebraskaQorannoo 5
- New YorkQorannoo 6
- North CarolinaQorannoo 3
- OhioQorannoo 6
- OregonQorannoo 3
- PennsylvaniaQorannoo 3
- South CarolinaQorannoo 3
- TexasQorannoo 7
- WashingtonQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07733765Dupilumab in the Treatment of Pediatric Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT05866562CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06562270A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 63 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06012240Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06747611Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT05398809Regeneron AA Multicenter (Dupilumab)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT05551793A Study of LAD603 in Adults With Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT07311564A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 14 · Saalaa hunda · Haaromfame 28-Elb-2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 04-Bit-2026 · NCT06826196CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Gur-2026 · NCT05745389Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Gur-2026 · NCT07242638Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT07133308Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.